by admin | Dec 13, 2024 | News & Opinions
By Technology Networks – A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel...
by admin | Dec 12, 2024 | News & Opinions
By Margarida Maia, PhD – Parkinson’s News Today – The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety and an easing in their symptoms over one year of follow-up, the...
by admin | Dec 11, 2024 | News & Opinions
By Nadine A Yehya – UCDavis Health – Funding promotes local production of CAR T-cell immunotherapy for cancer patients UC Davis Health’s Stem Cell Program has received a $500,000 grant from California health insurer Health Net to improve cancer patients’...
by admin | Dec 10, 2024 | News & Opinions
By Caroline Seydel – Genetic Engineering & Biotechnology News – Parkinson’s disease is characterized by the loss of dopamine-producing neurons. The current treatment is oral levodopa, which is taken up by brain neurons and converted to dopamine. But...
by admin | Dec 9, 2024 | News & Opinions
By Stem Cells Translational Medicine – Mesenchymal stem cells (MSCs) hold tremendous potential for regenerative medicine and the treatment of currently incurable diseases. These adult multipotent progenitor cells are essential for tissue regeneration and wound...
